We undertook the present study to establish reference data for serum thyroid function tests in a previously iodine-deficient area. Methods: Data from 4298 individuals, 20-79 years of age were available for the present analysis. Thyroid function (thyrotropin [TSH], free triiodothyronine [FT 3 ], and free thyroxine [FT 4 ]) and serum autoantibodies to thyroperoxidase (anti-TPOAb) were evaluated from blood samples. Thyroid structure and size were measured by ultrasound. Results: A reference population was selected comprising 1488 persons (825 men) by excluding subjects with known thyroid diseases, and with yet unknown thyroid disorders such as goitre, inhomogeneous thyroid pattern, nodules, hypoechogenicity and anti-TPOAb seropositivity. Reference intervals for serum TSH, FT 3 , and FT 4 were 0.25-2.12 mIU/L, 3.8-7.0 pmol/L, and 8.3-18.9 pmol/L, respectively. Reference serum TSH levels were not comparable to the reference values that were recently established for the U.S. population and most reference values slightly differed from the reference values provided by the manufacturers. Conclusions: The reference ranges of thyroid function tests in this formerly iodine-deficient region are distinct from the reference ranges that were established in areas with iodine sufficiency. Creating a reference population in the present setting should include thyroid ultrasound in order to exclude yet undiagnosed thyroid disorders.
Introduction

T
HE PATTERN OF thyroid diseases in a population mainly depends on the regional status of iodine supplementation. Several prevention programs have been introduced in order to normalize iodine supplementation by iodization of drinking water or table salt leading to an improvement of the iodine supply in many iodine-deficient parts of the world. The extent of iodine supplementation, however, varies widely among populations ranging from the status of below the normal level to a tendency toward an oversupply.
Recently, data from the NHANES III study (1) were analyzed to reassess reference intervals for laboratory thyroid tests for the general U.S. population. In that population, the iodine supply has been sufficient and partly even excessive for several decades. This situation is not comparable with most parts of Europe. Iodine supplementation programs were introduced in many European countries during the last two decades. Iodine deficiency, however, persisted in 13 of 31 European countries (41.9%) in 2002 (2) or the iodine supply has been normalized but yet not reached the optimum in other countries (3) . Thus, in most European populations a higher prevalence of nodular goiter and consequently a higher prevalence of subclinical hyperthyroidism and a lower prevalence of subclinical hypothyroidism could be expected compared to the U.S. population (4) . This should have an influence on the reference serum thyrotropin (TSH) concentrations. Moreover, there is currently few information available from population-based studies with respect to the reference range of serum free triiodthyronine (FT 3 ) and free thyroxine (FT 4 ) levels, respectively. Therefore, we undertook the present study to provide reference data for serum TSH, FT 3 , and FT 4 levels from a randomly selected sample of a German adult population. For this purpose, we analyzed data of the Study of Health in Pomerania (SHIP) allowing us to define a reference population by using a broad range of exclusion criteria.
Subjects and Methods
Study population
SHIP is a cross-sectional epidemiologic survey in western Pomerania, a region in the northeast of Germany. This re-gion was a formerly iodine-deficient area with endemic goiter (5, 6) . The prophylactic procedures that were gradually introduced during the 1980 have resulted in a stable and adequate iodine supply in the study area during the past decade. Currently, the median iodine excretion in this population is between 120 and 125 g/L (3). The total population of western Pomerania selected for SHIP comprised 212,157 inhabitants. A two-stage cluster sampling method was adopted from the WHO MONICA Project Augsburg, Germany (7) and yielded 12 five-year age strata (20 to 79 years) for both genders, each including 292 individuals. Data collection started in October 1997 and was finished in March 2001. The net sample (without migrated or deceased persons) comprised 6267 eligible subjects, and 4310 (68.8% of eligible subjects) participated (8) . For the present analysis, all 12 individuals with no blood drawn were excluded resulting in a whole study population of 4298 individuals who were available for this study. All participants gave written informed consent. The study conformed with the principles of the Declaration of Helsinki as reflected by an a priori approval of the Ethics Committee of the University of Greifswald.
Laboratory methods
Nonfasting blood samples were drawn from the cubital vein in the supine position. Serum TSH, FT 3 , and FT 4 levels were measured by immunochemiluminescent procedures (TSH and FT 4 , Byk Sangtec Diagnostica GmbH, Frankfurt, Germany; FT 3 , LUMItest, Brahms, Berlin, Germany). All assays were performed on the LIA-mat analyzer from Byk Sangtec according to the manufacturer's recommendations. The functional sensitivity of the TSH assay was 0.02 mIU/L. Reference ranges, provided by the manufacturer were: TSH, 0.3-3.0 mIU/L; FT 3 , 3.4-7.1 pmol/L; FT 4 , 7.7-23.2 pmol/L. The interassay coefficients of variations were 5.4% for TSH, 6.5% for FT 3 , and 7.0% for FT 4 . Serum levels of thyroid function tests were not available in a certain number of persons, 50 persons had missing data on TSH, 9 on FT 3 , and 7 on FT 4 . Serum autoantibodies to thyroperoxidase (TPOAb) were measured by an enzyme immunoassay (VARELISA, Elias Medizintechnik GmbH, Freiburg, Germany). The detection limit of this assay was 1 IU/mL. Serum anti TPOAb exceeding a level of 200 IU/mL were considered positive (9) . TSH and TPOAb were calibrated against the second international reference preparation of the Medical Research Council (MRC) 80/558 and 66/387, respectively.
Thyroid ultrasound
Thyroid ultrasonography was performed with an Ultrasound VST-Gateway with a 5-MHz linear array transducer (Diasonics, Santa Clara, CA). Thyroid volume was calculated as length ϫ width ϫ depth ϫ 0.479 [mL] for each lobe (10) . The intraobserver and interobserver reliabilities were assessed before the start of the study and afterwards semiannually during the study. All measurements of the thyroid volume showed Spearman correlation coefficients of greater than 0.85 and mean differences (Ϯ 2 SD) of the mean bias of less than 5% (Ͻ 25%). Goiter was defined as a thyroid volume exceeding 18 mL in women and 25 mL in men (11) . The normal thyroid echo pattern was classified as homogeneous. A homogeneous echo pattern with reduced echogenicity was defined as hypoechogenic. If the echo pattern was not homogeneous, showing small lesions or distinct diffuse abnormalities in the echotexture of the gland, it was classified as inhomogeneous. Nodular changes exceeding 10 mm in diameter were defined as nodules. The observer agreement for nodules was 100%.
Statistical analysis
Each age and gender strata was mathematically weighted to the age and gender distribution of the total population of western Pomerania in order to represent the standard population of adults. During analyses of thyroid function tests that weighting was used to adjust for any oversampling. Normality of distributions was tested according to Kolmogorov-Smirnov and Shapiro-Wilk statistic. The central 95% range between the 2.5th and the 97.5th percentiles was taken to be the reference interval and the two-sided nonparametric 0.90 confidence interval were calculated for the lower as well as upper reference value (12) . Data on quantitative characteristics are expressed as median and range. Data on qualitative characteristics are expressed as percent values or absolute numbers as indicated. All statistical analyses were performed with SPSS software, version 11.5.1 (SPSS GmbH Software, Munich, Germany).
Results
Kolmogorov-Smirnov and Shapiro-Wilk tests indicated that all measures for serum TSH, FT 3 , and FT 4 levels were not normally distributed in the whole population. Also log transformation of the serum TSH concentrations did not produce a normal distribution. Therefore, all results of descriptive statistics are given with nonparametric values.
We separated the 349 persons with known thyroid disease or who were taking thyroid medications and an additional 34 subjects suspected of having a possible thyroid disorder leaving a sample of 3915 individuals (2032 men, 1883 women) who represented the disease-free population. In this disease-free population, there were 1406 persons with goiter (36.1%), 1183 persons with an inhomogeneous thyroid echo pattern, (30.2%) and 181 persons with a hypoechogenic thyroid echo pattern (4.6%), 766 persons having at least one thyroid nodule (19.6%), and 152 persons with positive serum anti-TPOAb (4.1%). Altogether, 2427 individuals of the disease-free population (62.0%; 1207 men, 1220 women) had at least one yet unknown thyroid disorder. By excluding these individuals, the reference population was provided that included 1488 persons (825 men, 663 women). a Serum TSH levels in the whole study population decreased with age resulting in a median in the oldest age decade that was 39% lower than the median among the 20-29 year old subjects (Table 1 ). There was also an age-related decline of serum FT 3 levels, its extent, however, was 5% and therefore less pronounced than the age-related decline observed for serum TSH. There were no clear gender-specific differences with respect to the serum TSH and FT 3 concentrations. Serum FT 4 levels slightly decreased with age in men, but increased with age in females. Thyroid function tests in a In this paragraph all numbers and percentages are given as nonstandardized data.
the disease-free population exhibited similar trends as identified in the whole population (Table 1) .
Although individuals with known thyroid disorders were excluded from the disease-free population, there are several thyroid characteristics that are known to be associated with impaired thyroid function. These disorders were analyzed with regard to serum TSH, FT 3 , and FT 4 levels. Persons with previously unidentified goiter had 15%-32% lower median serum TSH levels compared to persons in the disease-free population. Males with goiter slightly tended toward lower Continuous data are given as median (interquartile range). All data standardized against the population of western Pomerania.
The whole study population comprises all persons who participated in the Study of Health in Pomerania (SHIP) and who had blood drawn. All persons with known thyroid disorders are excluded from the disease-free population.
TSH, thyrotropin; FT 3 , free triiodothyronine; FT 4 , free thyroxine. Data are given as median (interquartile range). All data standardized against the population of western Pomerania. a n ϭ 2, calculation of interquartile range not possible. The disease-free population represents all participants of the Study of Health in Pomerania (SHIP) with blood drawn who had no known thyroid disorder.
TPOAb, serum autoantibodies to thyroperoxidase; TSH, thyrotropin; FT 3 , free triiodothyronine; FT 4 , free thyroxine.
serum FT 3 and FT 4 levels, whereas in females with goiter no such tendency was observed ( Table 2 ). Compared to the results that were found in persons with goiter, similar trends were observed in persons with inhomogeneous thyroid echo pattern (data not shown) and in persons with nodules ( Table  2) . Low serum TSH concentrations were especially present in males 20 to 49 years of age and females 20 to 29 years of age with nodules. Compared to the total disease-free population, there was a trend toward higher serum TSH levels in male and female subjects with positive anti TPOAb and higher serum FT 3 concentrations in men with anti TPOAb seropositivity ( Table 2 ). Similar observations were made for disease-free persons who had a hypoechogenic thyroid pattern (data not shown).
In the reference population, the age-related decline of the median serum TSH levels was less pronounced compared to the whole and the disease-free population (Table 3) . Serum FT 3 levels in both genders and serum FT 4 levels in males slightly declined with age. The only relevant age-dependent trend with respect to the 2.5th and the 97.5th percentile was seen for serum TSH, but not for FT 3 and FT 4 levels (data not shown). Particularly, the 2.5th percentile of serum TSH decreased below 0.2 mIU/L in older subjects. However, the number of subjects and thus the precision of the estimation was fairly low especially in the older age decades. Therefore, we dichotomized our population according to age to analyze the reference intervals of thyroid function tests (Table 4) .
In order to assess practical consequences, the reference ranges that were derived from the present study were compared to those reference intervals provided by NHANES (1) and the manufacturer, respectively (Fig. 1, Table 5 ). By using the U.S. reference values instead of the reference intervals derived from the present study the prevalence of decreased serum TSH levels would be 3.2 times higher and the prevalence of increased serum TSH levels would be 3.8 times lower in the SHIP population. Remarkable differences between the manufacturer`s and our reference data were with respect to elevated serum TSH and FT 4 as well as decreased FT 3 and FT 4 levels. The prevalence of these laboratory thyroid test abnormalities were two to three times higher using the reference values that derived from the present study (Table 6 ).
Discussion
In this paper reference values for thyroid function tests were analyzed using data that were derived from a German regional population. To the best of our knowledge this is the first study from central Europe that was aimed at analyzying reference intervals for serum thyroid function test in a formerly iodinedeficient region with a population-based approach.
As expected, reference intervals for serum TSH were substantially different from those recently established for the U.S. population (1) . In comparison to the NHANES study VÖLZKE ET AL. 282 Data are given as median (interquartile range). All data standardized against the population of western Pomerania.
All persons with known thyroid disorder, with goiter, nodules, and abnormal thyroid echo patterns or positive anti-TPOAb Ͼ 200 IU/mL were excluded from the reference population. TSH, thyrotropin; FT 3 , free triiodothyronine; FT 4 , free thyroxine; TPOAb, serum autoantibodies to thyroperoxidase. All data standardised against the population of western Pomerania. Reference values were analyzed in a reference population. All persons with known thyroid disorder, with goiter, nodules, and abnormal thyroid echo patterns or positive serum anti-TPOAb Ͼ 200 IU/mL were excluded from the reference population.
CI, confidence interval; TSH, thyrotropin; FT 3 , free triiodothyronine; FT 4 , free thyroxine.
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(1), the distribution of serum TSH levels in the present study was moved to the left resulting in lower and upper TSH reference values that were approximately 50% lower than in the American population. Although NHANES data obtained ethnic influences on the serum TSH distribution, this could not explain the extent of the difference. Rather, the different extent of iodine supply-sufficient to excess in the NHANES versus previously deficient in the SHIP population-seems to be the most plausible reason for this. Methodologic differences of the TSH assays used in both studies cannot fully be ruled out as having contributed at least partly to those varying findings. The method of selecting the population for establishing reference intervals influences the reference ranges. From Europe, mostly reference data of thyroid function tests are available that were derived from healthy blood donors without further examinations of the thyroid (13) or small, clinically recruited samples (14, 15) . Besides the possible selection bias there is major disadvantage by the lack of an evaluation of asymptomatic iodine deficiency-related disorders. Thus, in comparison to the reference values provided by the manufacturer, the present analyses revealed a reference interval for serum TSH and FT 4 that was narrower and moved to the left. Furthermore, our data obtained a smaller lower reference value for serum FT 3 . Given the potential clinical and economic impact, the present study emphasises the need for careful analysis of reference values.
Another study used data of the population-based Danthyr cohort to analyze reference values of serum thyroid function tests (16) . In keeping with the present data, the serum FT 3 reference range was 3.6-6.9 pmol/L. Reference values for serum FT 4 levels were somewhat higher (9.8-20.4 pmol/L) than the FT 4 reference values analyzed from the present study. Differences may be explained by methodologic details. While the Danish study (16) established the FT 4 reference interval after exclusion of persons with known thyroid disease or serum TSH outside the reference interval, the present analyses also considered thyroid ultrasound in order to select the reference population. Furthermore, the lack of an international calibration standard for FT 4 limits the comparability of different methods.
Current U.S. guidelines recommend that, "serum TSH reference intervals should be established using specimens from TPOAb-negative, ambulatory, euthyroid subjects who have Data are given as numbers (percentage). The numbers and percentage indicate prevalence and prevalence rates that would be found by using the reference ranges that were provided by NHANES, the manufacturer, and SHIP, respectively. All data standardized against the population of western Pomerania.
SHIP, Study of Health in Pomerania; TSH, thyrotropin; FT 3 , free triiodothyronine; FT 4 , free thyroxine.
FIG. 1.
Comparisons of serum thyrotropin (TSH), free triiodothyronine (FT 3 ), and free thyroxine (FT 4 ) reference intervals established for the U.S. population (NHANES, 1), provided by the manufacturer and analysed by the present study (SHIP).
no personal or family history of thyroid dysfunction and no visible goiter" (17) . According to the findings of the present analyses a further sonographic evaluation of asymptomatic iodine deficiency-related disorders such as goiter, inhomogeneous thyroid echo pattern, and thyroid nodules should be recommended if reference values for thyroid function tests have to be evaluated in currently or previously iodine deficient regions.
In agreement with other studies (13, 18 ) the present analyses revealed a decline by age for serum TSH and FT 3 levels that was more pronounced for TSH. While the FT 3 decline may reflect alterations in the ageing thyroid, the age-related TSH decrease may further be the result of a cohort effect: older people have been exposed to iodine deficiency longer than younger persons. Contradictory results exist for the association between age and serum FT 4 levels. While there was a slight age-dependent decline in one study (13) , another study (18) revealed the opposite, higher FT 4 levels in the elderly. We found a slight age-related FT 4 decline in the male population, whereas no clear trend could be demonstrated in the female reference population. A number of reasons, namely, specific patterns of medication, may have accounted for these differences.
This study has some limitations. First, these analyses are representative for western Pomerania, the representativeness of the present findings for other regions could not be assessed with the present data. However, generalizibility mainly depends on the extent of the iodine supply in these areas. Because most parts of Europe are currently turning to iodine sufficiency, the present data may be used for those areas as well. Second, having serum concentrations within or outside a reference interval does not necessarily mean to be healthy or diseased. As a result of intraindividual variation, a single test result within the laboratory reference range does not exclude an abnormal thyroid function (19) . Thus, in some case with suspected thyroid disease, repeated measurements of thyroid function may be useful. In addition, the relevance of low serum TSH levels within the normal range as a possible marker for total and vascular mortality has to be further explored (20) .
We conclude that the reference ranges of thyroid function tests in this formerly iodine-deficient region are distinct from the reference ranges that were established in areas with iodine sufficiency. Creating a reference population in the present setting should include thyroid ultrasound in order to exclude yet undiagnosed thyroid disorders.
